Publications by authors named "Callan Bleick"

Claim this Profile
O
Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates.
Callan R Bleick, Sean R Van Helden, Andrew D Berti, Rita Richa, Susan M Lehman

Antimicrob Agents Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of biofilm exopolysaccharide composition on bacteriophage and bacteriophage-antibiotic combination activity.
Sean R Van Helden, Callan R Bleick, Dana J Holger, Amer El Ghali, Jose Alexander

Antimicrob Agents Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor regarding "Long-term sustainability of improvements in antibiotic prescribing after implementation of a local guideline for the management of patients hospitalized with skin and soft tissue infection" by Frappa .
Callan Bleick

Antimicrob Steward Healthc Epidemiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefepime-taniborbactam: Ushering in the era of metallo-β-lactamase inhibition.
Sean R Van Helden, Mohammed Al Musawa, Callan R Bleick, Shelbye R Herbin, Michael J Rybak

Pharmacotherapy· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aztreonam-avibactam: The dynamic duo against multidrug-resistant gram-negative pathogens.
Mohammed Al Musawa, Callan R Bleick, Shelbye R Herbin, Kaylee E Caniff, Sean R Van Helden

Pharmacotherapy· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens.
Ashlan J Kunz Coyne, Mirna Eshaya, Callan Bleick, Samantha Vader, Biswajit Biswas

Microbiol Spectr· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an simulated endocardial pharmacokinetic/pharmacodynamic model.
Ashlan J Kunz Coyne, Callan Bleick, Kyle Stamper, Razieh Kebriaei, Arnold S Bayer

Antimicrob Agents Chemother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms.
Ashlan J Kunz Coyne, Kyle Stamper, Callan Bleick, Razieh Kebriaei, Susan M Lehman

Microbiol Spectr· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staphylococcal biofilm: penetration and bioavailability of vancomycin with or without rifampin.
Kathryn E Daffinee, Emily T O'Neill, Callan R Bleick, Geoff Williams, Valentin Antoci

Diagn Microbiol Infect Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulbactam-durlobactam: A novel β-lactam-β-lactamase inhibitor combination targeting carbapenem-resistant Acinetobacter baumannii infections.
Amer El-Ghali, Ashlan J Kunz Coyne, Kaylee Caniff, Callan Bleick, Michael J Rybak

Pharmacotherapy· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis